Finasteride vs Minoxidil
Finasteride blocks 5-alpha reductase, reducing scalp DHT — the upstream driver of androgenetic alopecia. Minoxidil is a vasodilator that prolongs the anagen (growth) phase. They address different mechanisms and are most commonly used together. Topical formulations reduce systemic exposure relative to oral.
Finasteride is appropriate when the goal is to address the upstream hormonal driver of androgenetic alopecia, particularly in TRT-context candidates with scalp-hair concerns.
Minoxidil is appropriate when the goal is to extend the follicular growth phase, and is frequently combined with finasteride in provider-reviewed pathways.
Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Can they be used together?
Yes — combination is standard. The oMeds topical pathway is designed around this layering under provider review.
Does TRT require finasteride?
No. Only candidates with androgenetic predisposition need DHT-aware adjuncts. The hair-loss conversation is part of TRT candidacy review.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment